Showing posts with label Zoom. Show all posts
Showing posts with label Zoom. Show all posts

Saturday, 25 April 2020

2020 Dupuytren Award

The yearly Dupuytren Award has been given, this time two papers qualified, one in the basic research section and one in the clinical research section. We send warm congratulations to David Izadi and Thomas Layton, and to Anna Zachrisson, Allan Ibsen Sörensen and  Joakim Strömberg, and please keep up the good work! https://www.dupuytren-online.info/dupuytren_award.html

Research has taken a step back,but it has not stopped, in the worst case it has been temporarily halted and will continue as soon as lockdown restrictions ease off.
Meanwhile we are working on a new online project, I will tell more when we have done it!
Preparations for the conference will start again next year.

From the Dupuytren Research Group in America:
- The International Dupuytren Data Bank is in its fifth year and moving forward. Read about what we've learned, what's happening with blood test research, and how to confirm your contact information for the long-awaited IDDB update survey soon to go out:https://dupuytrens.org/2020-iddb-progress-and-findings/.
 
Dupuytren Zoom Discussion Groups are here - for patients, healthcare providers, and scientists. See what this can do for you:
 https://dupuytrens.org/zoom-dupuytren-discussion-groups/ 
 

Friday, 3 May 2019

Big news and bigger news!

I am not sure which is the biggest news item here!
We are planning a second webinar. This one will be on PNF, speakers are Prof Tim Davis, Prof Steven Hovius (who did the lipofilling trial), Dr Gary Pess (who performs more PNF than anyone else in the US probably), Prof Chris Bainbridge (from the Pulvertaft Centre in Derby), and patients Ian Ireland (personal experience) and Anna Schurer (PNF and the NHS).
It will be the 20th May, at 8pm GMT. As before it will be using a program called Zoom. We have quite a few places left, so if you're interested and haven't let me know yet, send me an email!
anna@dupuytrens-society.org.uk

The second news item: Oxfords own professor Jagdeep Nanchahal has won the 2019 Dupuytren's Award, for his work on adalimumab in Dupuytren's (the RIDD trial) This award was sponsored by patients from the BDS and the (now defunct) American DDSG Facebook group, as well as the IDS (International Dupuytren Society). A worldwide acknowledgement for the study. Many congratulations to Prof Nanchahal and his team.
https://www.dupuytren-online.info/dupuytren_award.html